Annual CFI
$47.52 M
+$65.58 M+363.10%
December 31, 2023
Summary
- As of February 7, 2025, OMGA annual cash flow from investing activities is $47.52 million, with the most recent change of +$65.58 million (+363.10%) on December 31, 2023.
- During the last 3 years, OMGA annual CFI has risen by +$49.32 million (+2728.04%).
- OMGA annual CFI is now at all-time high.
Performance
OMGA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$16.00 K
+$380.00 K+95.96%
September 30, 2024
Summary
- As of February 7, 2025, OMGA quarterly cash flow from investing activities is -$16.00 thousand, with the most recent change of +$380.00 thousand (+95.96%) on September 30, 2024.
- Over the past year, OMGA quarterly CFI has dropped by -$4.48 million (-100.36%).
- OMGA quarterly CFI is now -100.07% below its all-time high of $24.05 million, reached on June 30, 2023.
Performance
OMGA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$6.19 M
+$708.00 K+12.91%
September 30, 2024
Summary
- As of February 7, 2025, OMGA TTM cash flow from investing activities is $6.19 million, with the most recent change of +$708.00 thousand (+12.91%) on September 30, 2024.
- Over the past year, OMGA TTM CFI has dropped by -$23.74 million (-79.31%).
- OMGA TTM CFI is now -91.67% below its all-time high of $74.34 million, reached on June 30, 2023.
Performance
OMGA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OMGA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +363.1% | -100.4% | -79.3% |
| 3 y3 years | +2728.0% | -100.4% | -79.3% |
| 5 y5 years | +5468.9% | -100.4% | -79.3% |
OMGA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +217.6% | -100.1% | +100.0% | -91.7% | +106.3% |
| 5 y | 5-year | at high | +217.6% | -100.1% | +100.0% | -91.7% | +106.3% |
| alltime | all time | at high | +217.6% | -100.1% | +100.0% | -91.7% | +106.3% |
Omega Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.00 K(-96.0%) | $6.19 M(+12.9%) |
| Jun 2024 | - | -$396.00 K(-108.9%) | $5.49 M(-81.7%) |
| Mar 2024 | - | $4.46 M(+108.6%) | $29.93 M(-37.0%) |
| Dec 2023 | $47.52 M(-363.1%) | $2.14 M(-395.6%) | $47.52 M(-24.6%) |
| Sep 2023 | - | -$724.00 K(-103.0%) | $63.03 M(-15.2%) |
| Jun 2023 | - | $24.05 M(+9.1%) | $74.34 M(+20.8%) |
| Mar 2023 | - | $22.05 M(+24.9%) | $61.56 M(-440.8%) |
| Dec 2022 | -$18.06 M | $17.65 M(+66.7%) | -$18.06 M(-75.9%) |
| Sep 2022 | - | $10.59 M(-6.0%) | -$74.84 M(-12.8%) |
| Jun 2022 | - | $11.27 M(-119.6%) | -$85.78 M(-12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$57.57 M(+47.1%) | -$97.92 M(+142.4%) |
| Dec 2021 | -$40.40 M(+2134.5%) | -$39.13 M(>+9900.0%) | -$40.40 M(+2156.9%) |
| Sep 2021 | - | -$353.00 K(-59.2%) | -$1.79 M(-27.9%) |
| Jun 2021 | - | -$866.00 K(+1704.2%) | -$2.48 M(+38.9%) |
| Mar 2021 | - | -$48.00 K(-90.8%) | -$1.79 M(-1.1%) |
| Dec 2020 | -$1.81 M(+104.3%) | -$523.00 K(-50.0%) | -$1.81 M(+40.7%) |
| Sep 2020 | - | -$1.05 M(+511.7%) | -$1.28 M(+437.7%) |
| Jun 2020 | - | -$171.00 K(+151.5%) | -$239.00 K(+251.5%) |
| Mar 2020 | - | -$68.00 K | -$68.00 K |
| Dec 2019 | -$885.00 K | - | - |
FAQ
- What is Omega Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Omega Therapeutics?
- What is Omega Therapeutics annual CFI year-on-year change?
- What is Omega Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Omega Therapeutics?
- What is Omega Therapeutics quarterly CFI year-on-year change?
- What is Omega Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Omega Therapeutics?
- What is Omega Therapeutics TTM CFI year-on-year change?
What is Omega Therapeutics annual cash flow from investing activities?
The current annual CFI of OMGA is $47.52 M
What is the all time high annual CFI for Omega Therapeutics?
Omega Therapeutics all-time high annual cash flow from investing activities is $47.52 M
What is Omega Therapeutics annual CFI year-on-year change?
Over the past year, OMGA annual cash flow from investing activities has changed by +$65.58 M (+363.10%)
What is Omega Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of OMGA is -$16.00 K
What is the all time high quarterly CFI for Omega Therapeutics?
Omega Therapeutics all-time high quarterly cash flow from investing activities is $24.05 M
What is Omega Therapeutics quarterly CFI year-on-year change?
Over the past year, OMGA quarterly cash flow from investing activities has changed by -$4.48 M (-100.36%)
What is Omega Therapeutics TTM cash flow from investing activities?
The current TTM CFI of OMGA is $6.19 M
What is the all time high TTM CFI for Omega Therapeutics?
Omega Therapeutics all-time high TTM cash flow from investing activities is $74.34 M
What is Omega Therapeutics TTM CFI year-on-year change?
Over the past year, OMGA TTM cash flow from investing activities has changed by -$23.74 M (-79.31%)